A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin “add-back” regimens for women with leiomyomata uteri - Friedman,A.J.; Daly,M.; Juneau-Norcross,M. (J Clin Endocrinol Metab, 1993)